New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models
摘要:
During a screen for compounds that could inhibit cell proliferation, a series of new tubulin-binding compounds was identified with the discovery of oxadiazoline 1 (A-105972). This compound showed good cytotoxic activity against non-multi-drug-resistant and multi-drug-resistant cancer cell lines, but its utility in vivo was limited by a short half-life. Medicinal chemistry efforts led to the discovery of indolyloxazoline 22g (A-259745), which maintained all of the in vitro activity seen with oxadiazoline 1, but also demonstrated a better pharmacokinetic profile, and dose-dependent in vivo activity. Over a 28 day study, indolyloxazoline 22g increased the life span of tumor-implanted mice by up to a factor of 3 upon oral dosing. This compound, and others of its structural class, may prove to be useful in the development of new chemotherapeutic agents to treat human cancers.
New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models
摘要:
During a screen for compounds that could inhibit cell proliferation, a series of new tubulin-binding compounds was identified with the discovery of oxadiazoline 1 (A-105972). This compound showed good cytotoxic activity against non-multi-drug-resistant and multi-drug-resistant cancer cell lines, but its utility in vivo was limited by a short half-life. Medicinal chemistry efforts led to the discovery of indolyloxazoline 22g (A-259745), which maintained all of the in vitro activity seen with oxadiazoline 1, but also demonstrated a better pharmacokinetic profile, and dose-dependent in vivo activity. Over a 28 day study, indolyloxazoline 22g increased the life span of tumor-implanted mice by up to a factor of 3 upon oral dosing. This compound, and others of its structural class, may prove to be useful in the development of new chemotherapeutic agents to treat human cancers.
Abstract A facile synthesis of 1,4-disubstituted1,2,3-triazoles was achieved from nitrobenzenes and terminal alkynes under mild conditions. The reactions were successful for nitrobenzenes and terminal alkynes bearing various functionalities, from which the 1,2,3-triazole derivatives were smoothly synthesized through a four-step one-pot sequence.
photopromoted, metal-free transannulation of phenyl azides for the synthesis of DNA-encoded seven-memberedrings. The transformation is efficiently achieved through a skeletal editing strategy targeting the benzene motif coupled with a Reversible Adsorption to Solid Support (RASS) strategy. A variety of valuable DNA-encoded seven-memberedring compounds, including DNA-encoded 3H-azepines, azepinones, and
在本报告中,我们提出了一种光促进、无金属的苯基叠氮化物转环反应,用于合成 DNA 编码的七元环。该转化是通过针对苯基序的骨架编辑策略与可逆吸附到固体支持物(RASS)策略相结合而有效实现的。现在可以获得多种有价值的 DNA 编码的七元环化合物,包括 DNA 编码的 3H-氮杂卓、氮杂酮和非天然氨基酸。至关重要的是,这种与 DNA 兼容的方案也可用于引入复杂分子,例如 Lorcaserin 和 Betahistine。将容易获得的苯环选择性地转化为高价值的七元环,为构建多样化和类药物的 DNA 编码库提供了一条有前途的途径。
Synthesis and Anticancer Activity of 5-[(1-Aryl-1H-1,2,3-triazol-4-yl)methyl]-10,11-dihydro-5H-dibenzo[b,f]azepines
作者:K. Sadanandam、P. Pinnoju、M. Sarasija
DOI:10.1134/s1070428024010184
日期:2024.1
novel series of 5-[(1-aryl-1H-1,2,3-triazol-4-yl)methyl]-10,11-dihydro-5H-dibenzo[b,f]azepine derivatives were synthesized by employing click chemistry approach starting from 10,11-dihydro-5H-dibenzo[b,f]azepine and evaluated for their cytotoxicity against a panel of three cancer cell lines (SiHa, MDA-MB-231, PANC-1). Many of the tested compounds exhibited significant anticanceractivity, and compound
摘要 通过以下方法合成了一系列新型 5-[(1-芳基-1 H -1,2,3-三唑-4-基)甲基]-10,11-二氢-5 H-二苯并[ b , f ]氮杂环庚烷衍生物采用点击化学方法从 10,11-二氢-5 H-二苯并[ b , f ]氮杂卓开始,并评估其对三种癌细胞系(SiHa、MDA-MB-231、PANC-1)的细胞毒性。许多测试的化合物表现出显着的抗癌活性,并且发现化合物4g是该系列中最有前途的类似物。